De los creadores de
-1-6-(1)_page0_image.2023-01-10-10-55-22.png/jcr:content/22-11198%20GAMING%20TRIDTAHLON%20ESPACIAL%20(2%20EDICI%C3%93N)-1-6%20(1)_page0_image.2023-01-10-10-55-22.png 400w,/.imaging/mte/sanofi-platform/img-w500/dam/dermatrain-es/22-11198-GAMING-TRIDTAHLON-ESPACIAL-(2-EDICIÓN)-1-6-(1)_page0_image.2023-01-10-10-55-22.png/jcr:content/22-11198%20GAMING%20TRIDTAHLON%20ESPACIAL%20(2%20EDICI%C3%93N)-1-6%20(1)_page0_image.2023-01-10-10-55-22.png 500w,/.imaging/mte/sanofi-platform/img-w600/dam/dermatrain-es/22-11198-GAMING-TRIDTAHLON-ESPACIAL-(2-EDICIÓN)-1-6-(1)_page0_image.2023-01-10-10-55-22.png/jcr:content/22-11198%20GAMING%20TRIDTAHLON%20ESPACIAL%20(2%20EDICI%C3%93N)-1-6%20(1)_page0_image.2023-01-10-10-55-22.png 600w,/.imaging/mte/sanofi-platform/img-w700/dam/dermatrain-es/22-11198-GAMING-TRIDTAHLON-ESPACIAL-(2-EDICIÓN)-1-6-(1)_page0_image.2023-01-10-10-55-22.png/jcr:content/22-11198%20GAMING%20TRIDTAHLON%20ESPACIAL%20(2%20EDICI%C3%93N)-1-6%20(1)_page0_image.2023-01-10-10-55-22.png 700w)
Este sitio web está dirigido exclusivamente al profesional sanitario facultado para prescribir o dispensar medicamentos en España | Web dirigida a R3 y R4 de dermatología de España.
De los creadores de
"Sample Pop Up Modal"
"Sample Pop Up Modal"
Living with atopic dermatitis (AD), a chronic inflammatory skin disease, can have a profound impact on a person’s overall quality of life, and on those caring for them. The physical symptoms of moderate-to-severe AD, which can include intense itch, skin dryness, cracking, crusting and oozing, can be difficult to manage.1 People living with this complex disease face uncertainty every day and may experience bullying and social isolation.2
While innovation in treatment is paramount, patients need high-quality, comprehensive care to manage all aspects of living with AD and have the best possible outcomes.
To help support improvements in quality of care for AD patients around the world, Sanofi and Regeneron commissioned and funded an independent report from KPMG that aims to explore, document, and share best practices in patient care for AD and its associated comorbidities globally, enabling clinics to identify ways to optimize the care they provide. The Improving Quality of Care in Atopic Dermatitis Report was based on a comprehensive examination of 32 centers that deliver AD care around the world, including hospitals and specialists’ offices. It identifies gaps in awareness and presentation, diagnosis and referral, treatment and management, and follow-up.
La información contenida en este sitio Internet está dirigida exclusivamente a profesional sanitario facultado para prescribir o dispensar medicamentos en España (requiere una formación especializada para su correcta interpretación). Sanofi promueve la prescripción de sus productos farmacéuticos en las condiciones establecidas en su ficha técnica. Pulse ACEPTAR si usted es profesional sanitario en España y desea continuar en este sitio o SALIR para ser redirigido al sitio Internet de Sanofi.